Rosai-Dorfman disease, also known as sinus histiocytosis, is a rare non-neoplastic disorder characterized by hypertrophy and proliferation of histiocytes, primarily in the lymph nodes and other organs of the lymphatic system. The disease often presents as asymptomatic enlargement of lymph nodes, and may occasionally be accompanied by systemic symptoms such as fever, anaerobic weight loss, and exanthema. Pathological features of the disease include active histiocytes with prominent cytoplasm, and "switching" effects in the cell structure may also be observed. From an etiological point of view, the exact causes of Rosai-Dorfman disease remain unclear, but it is assumed that it is associated with immune-mediated processes, although an infectious nature is also considered.
History of the disease and interesting historical facts
The first description of Rosai-Dorfman disease was made in 1965 by Israeli doctors M. Rosai and A. Dorfman, who observed a group of patients with similar clinical manifestations. Since its discovery, the disease has attracted the attention of researchers, and since then many articles have been published on the clinical expression and pathogenesis of the disease. In 2009, it was proposed to systematize data on the disease, and it was included in a number of medical classifications, including the International Classification of Diseases (ICD), where it was identified as D8. The main interest of the medical community is caused not only by the pathology itself, but also by the rarity of its occurrence, which makes cases of the disease unique and important for further study.
Epidemiology
Lack of statistical data makes it difficult to estimate the true prevalence of Rosai-Dorfman disease. However, available studies suggest that the incidence is approximately 0.5 per 100,000 people per year. Most reported cases occur in patients aged 20 to 40 years, but cases have also been documented in children and the elderly. The prevalence of the disease varies by region, but it is generally thought to be more common and aggressive in certain ethnic groups, which may indicate a genetic predisposition.
Genetic predisposition to this disease
In recent years, there have been suggestions about the presence of a genetic predisposition associated with Rosai-Dorfman disease. Studies devoted to the analysis of DNA of patients have identified its genetic markers. The most studied are mutations in the genes responsible for the function of T-lymphocytes and histiocytes. According to a number of studies, a small number of cases are associated with hereditary syndromes, such as Kostmann syndrome and G-duration syndrome. The appearance and proliferation of histiocytes may be associated with the activation of specific cellular signals, as well as with changes in the cytocline, promoting uncontrolled cell division.
Risk factors for the development of this disease
Several factors may predispose to the development of Rosai-Dorfman disease, although they are not yet fully understood. Among them are:
- Infectious agents such as the Epstein-Barr virus, which can affect the body's immune response.
- Determination of certain chemicals, including carcinogens, that affect the lymphatic system.
- Systemic diseases such as systemic lupus erythematosus or other autoimmune pathologies that may affect the function of the immune system.
- Genetic features and predisposition identified through family history.
Diagnosis of this disease
Diagnosis of Rosai-Dorfman disease is based on a combination of clinical, laboratory and radiological examination methods. The main symptoms include:
- Enlargement of the lymph nodes, most often in the neck.
- Fever and unexplained weight loss.
- Anaphylogram – sometimes the presence of other non-inflammatory exudates in the organs is observed.
Laboratory studies include a complete blood count to detect inflammatory changes. Radiologic studies such as CT or MRI may be used to visualize enlarged lymph nodes. In some cases, a biopsy is required to confirm the diagnosis, where histologic examination will demonstrate characteristic histiocyte morphology. Differential diagnosis should include other histiocytic and lymphoproliferative disorders such as Hodgkin's disease and non-Hodgkin's lymphomas.
Treatment
Treatment for Rosai-Dorfman disease may involve different approaches, depending on the severity of symptoms and the extent of the disease. A common approach involves observing the patient with mild symptoms, as in most cases the disease may resolve on its own.
Pharmacological treatment often includes:
- Corticosteroids to reduce inflammation.
- Immunosuppressants if the disease causes serious changes in the body.
- Antibiotics in case of concomitant infections.
Surgery may be necessary if serious complications arise, such as compression of important organs. Other treatment options may include radiation therapy, especially if the lesions are in an area that is exposed to higher radiation loads.
List of medications used to treat this disease
Medications recommended for the treatment of Rosai-Dorfman disease include:
- Dexamethasone.
- Prednisolone.
- Methotrexate.
- Cyclosporine.
- Rituximab.
Disease monitoring
Monitoring of patients with Rosai-Dorfman disease is required to promptly identify possible complications and assess the response to therapy. Control stages include regular clinical examinations, biochemical tests, and imaging techniques such as CT and MRI. The prognosis is favorable in most cases, especially for patients with isolated lymph node involvement, but there are cases with an aggressive course and the possibility of relapse after completion of treatment. Complications may include superinfections, cicatricial changes, and extensive organ damage.
Age-related features of the disease
The age of patients is important in the diagnosis and treatment of Rosai-Dorfman disease. In children, the disease is often observed with less pronounced symptoms and may resolve spontaneously. Adult patients show a more severe course with a greater risk of systemic manifestations, which may require more intensive treatment. In the elderly, although cases of the disease are significantly fewer, accentuated manifestations are observed, which is associated with a lower response of the body to therapy.
Questions and Answers
- What are the main symptoms of Rosai-Dorfman disease? The main symptoms include swollen lymph nodes, fever, unexplained weight loss and rash.
- How is this disease diagnosed? Diagnosis is based on clinical examination, laboratory tests, radiological studies and, if necessary, biopsy.
- What are the treatments for Rosai-Dorfman disease? Treatment may include observation, drug therapy (corticosteroids, immunosuppressants), and, in case of complications, surgery.
- What is the prognosis for Rosai-Dorfman disease? In most cases, the prognosis is favorable, but in some situations, relapses and complications may occur.
- Are there any risk factors for developing the disease? Yes, these include infectious agents, genetic predisposition and certain systemic diseases.
